Product Description: Cinaciguat is an activator of guanylate cyclase (sGC), and used for acute decompensated heart failure.
Applications: COVID-19-immunoregulation
Formula: C36H39NO5
References: [1]Mátyás C, et al. The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus. Cardiovasc Diabetol. 2015 Oct 31;14:145./[2]Reinke Y, et al. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats. Format: AbstractSend to Eur J Pharmaco/[3]Cosyns SM, et al. Influence of cinaciguat on gastrointestinal motility in apo-sGC mice. Neurogastroenterol Motil. 2014 Nov;26(11):1573-85.
CAS Number: 329773-35-5
Molecular Weight: 565.70
Compound Purity: 99.73
Research Area: Cardiovascular Disease
Solubility: DMSO : ≥ 50 mg/mL
Target: Guanylate Cyclase
Deutsch
English
